Abstract:OBJECTIVE:To explore the feasibility of application of multiplex quantitative fluorescent PCR with non-polymorphic loci in prenatal diagnosis of aneuploidies.METHODS:From Mar 2006 to Nov 2007, a total of 63 samples were collected from the Department of Obstetrics and Gynecology, Affiliated Drum Tower Hospital of Medical College, Nanjing University, including 54 villous samples obtained for karyotyping because of spontaneous abortion, six amniotic fluid samples of second trimester and three umbilical cord blood samples of third trimester. Blood samples of 60 healthy adults were obtained at the same time as a control group, including 30 males and 30 females. Non-polymorphic QF-PCR was performed on both testing group and control group for the detection of aneuploidies. The Amelogenin gene (AMXY) was selected as an internal control, and dosage quotiety (DQ) of each locus was calculated according to the known formula. If DQ was between 0.7 and 1.3, the sample was considered as normal. If the figure turned out to be > 1.3 or < 0.7, a potential duplication or deletion of the corresponding gene or chromosome was indicated. If the results implied numerical abnormalities in more than one euchromosome, sex chromosome aneuploidies should be considered. Cell culture and karyotyping were carried out for every sample simultaneously. The results of non-polymorphic QF-PCR were checked with karyotypes.RESULTS:(1) In the control group, all female samples presented only an AMX peak for sex chromosome while all males showed AMX and AMY amplified peaks. The AMY/AMX ratios were between 0.7 - 1.3, and SD was between 0.05 - 0.12. (2) Among 19 QF-PCR abnormal cases, 13 cases were proved by karyotyping. Of the six cases which turned out to be conflicting, one case of trisomy 18 shown by karyotyping was not completely detected by QF-PCR, a locus on chromosome 18 implied trisomy, while another turned out to be normal (DQ = 1.28). Four cases were detected by non-polymorphic QF-PCR as trisomies but showed normal female karyotype because of maternal contamination during cell culture. A karyotypingly '46, XY' case did not present an AMY peak. Thirty-six out of 44 (82%) normal results implied by non-polymorphic QF-PCR were in accordance with cytogenetic analysis. Of the other eight cases, one case which failed cytogenetic analysis was detected by QF-PCR as normal. Four cases showed multiploidy by karyotyping but normal in QF-PCR analysis, including three cases of 69, XXX, one case of 92, XXXX and one case of 45, XX, rob (13;21). The other two cases that showed normal male results turned out to be normal female karyotypes.CONCLUSIONS:Prenatal aneuploidy detection by non-polymorphic QF-PCR is feasible in a clinical diagnostic setting. With the advantages of high throughput, rapidness and low cost, this method shows a good prospect in clinical application.

Prenatal diagnosis for chromosome aneuploidies in 50 amniotic fluid samples with fluorescence in situ hybridization

Prenatal Diagnosis of Common Chromosomal Aneuploidies on Uncultured Amniotic Fluid Cells by Fluorescence in Situ Hybridization

Prenatal Diagnosis of Common Chromosomal Aneuploidies by Fluorescence in Situ Hybridization

Rapid Prenatal Diagnosis of Chromosome Aneuploidies In60 Uncultured Amniotic Fluid Samples by Fluorescence in Situ Hybridization

Application of fluorescence in situ hybridization in prenatal diagnosis of chromosome abnormalities

Clinical Assessment of Fluorescence in Situ Hybridization for Prenatal Diagnosis of Chromosomal Abnormalities.

A Quality Assurance Scheme for Prenatal Detection of Aneuploidy Based on Developing Chimeric Quality-Control Cells

Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing

Fluorescence in situ hybridization and aminocytes karyotyping for 1809 aminotic cells assay

[Rapid Detection of Chromosomes X and Y Using Dual-Color Primed in Situ Labeling Technique].

Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.

Fluorescence in situ hybridization and aminocytes karyotyping for 1 809 aminotic cells assay

Comparison of Quantitative Fluorescent Polymerase Chain Reaction (QF-PCR) and Conventional Cytogenetic Analysis in Detection of Fetal Anueploidies

Application of Fluorescence in Situ Hybridization in Diagnosis of Mother Serum Markers Abnormality

Prenatal Diagnosis of Down Syndrome Using Cell-Free Fetal DNA in Amniotic Fluid by Quantitative Fluorescent Polymersase Chain Reaction.

Study on the clinical application of FISH in prenatal diagnosis and detection of abortion tissue

Evaluation of the Practical Applications of Fluorescence in Situ Hybridization in the Prenatal Diagnosis of Positive Noninvasive Prenatal Screenings

Detecting fetal chromosomal aneuploidy by Illumina-solexa sequencing DNA in maternal plasma

[Application of Fluorescence in Situ Hybridization in the Diagnosis of Genetic Diseases].

Analysis of amniotic fluid chromosome karyotype of 7738 cases

[Application of Multiplex Quantitative Fluorescent PCR with Non-Polymorphic Loci in Prenatal Diagnosis].